By providing a tangible example of centralized monitoring implementation, the paper showcases the benefits of utilizing a risk-based approach to clinical trial monitoring, significantly reducing ...

As clinical trial complexities grow, ICH E6 (R3) updates emphasize smarter monitoring, greater participant focus, and a stronger tech role.

A study published in the International Journal of Radiation Oncology*Biology*Physics demonstrates that clinicopathology (CP) ...

More information: Patient-Reported Outcomes for Low-Risk Ductal Carcinoma In Situ A Secondary Analysis of the COMET Randomized Clinical Trial, JAMA Oncology (2024). DOI: 10.1001/jamaoncol.2024.6556 ...

The American Gastroenterology Association (AGA) Institute issued new clinical practice guidelines, providing evidence-based recommendations for managing hepatitis B reactivation (HBVr) in at-risk ...

Decentralized Clinical Trials (DCTs) are transforming how we collect clinical data, but this evolution brings unprecedented challenges in data quality, complexity, and integration.

Among patients with hormone receptor (HR)-positive, HER2-negative, low-risk ductal carcinoma in situ (DCIS), those who underwent active monitoring had similar two-year invasive ipsilateral breast ...

Among patients with hormone receptor (HR)-positive, HER2-negative, low-risk ductal carcinoma in situ (DCIS), those who underwent active monitoring had similar two-year invasive ipsilateral breast ...

More recently, the phase 3 QuiRedex trial evaluated early treatment with lenalidomide plus dexamethasone (Rd) as compared with active monitoring in patients with high-risk smoldering multiple ...

News GlobeNewswire Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical Trial Based on Positive Recommendation from Data Safety and Monitoring Committee (DSMC) ...